NRXP - long - catalyst playNRX Pharmaceuticals Inc is a clinical-stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.41 USD
−25.13 M USD
0.00 USD
14.03 M
About NRX Pharmaceuticals, Inc.
Sector
Industry
CEO
Jonathan C. Javitt
Website
Headquarters
Wilmington
Founded
2017
FIGI
BBG00JCWDN63
NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.
$NRXP NRX Pharmaceuticals Inc NASDAQ:NRXP NRX Pharmaceuticals Inc
Long term PTs 1.20 - 1.50 - 3.50 - 10 and higher
NRx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders. Its products include ZYESAMI, an investigational drug that has
NRXP all time low! 2 X Phase 3 clinical trials! NRx Pharmaceuticals, Inc. (NRXP) has two Phase III assets for which it has Fast Track and Breakthrough Therapy designation, respectively: intravenous ZYESAMI® for Critical COVID-19 and NRX-101 for bipolar depression with suicidality.
52 Week Range 2.38 - 48.80.
in 2020 the stock was $77.
My price
NRX Pharma USASun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series
Focus: Worldwide
By Sun Storm Investment Research & NexGen Wealth Management Service
A Profit & Solutions Strategy & Research
Trading | Investment | Stocks | ETF | Mutua
#NRXP 12-22-66
NRX Pharmaceuticals (NRXP) said Friday data from a mid-stage trial showed that the BriLife COVID19 vaccine may be able to protect against the delta variant of SARS-CoV-2, the virus that causes COVID-19.
In the phase 2 study, 10 out of the 11 samples taken from participants to be tested for antibo
NRXP COVID-19 Vaccine Effectiveness Against Delta VariantNRx Pharmaceuticals announced that its BriLife COVID-19 Vaccine is Effectiveness Against Delta Variant.
Information was released by Israel Institute for Biological Research.
Since the pandemic isn`t over, there is a place in the market for new developers that have effective vaccines.
I consider th
NRXP 15min Scalpers editiontest
NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered i
#NRXP Huge Gain May Reach $64 Sector: Health Technology
Industry: Pharmaceuticals: Major
NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of NRXP is 1.92 USD — it has decreased by −2.96% in the past 24 hours. Watch NRX Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange NRX Pharmaceuticals, Inc. stocks are traded under the ticker NRXP.
NRXP stock has risen by 2.60% compared to the previous week, the month change is a −5.74% fall, over the last year NRX Pharmaceuticals, Inc. has showed a −59.55% decrease.
We've gathered analysts' opinions on NRX Pharmaceuticals, Inc. future price: according to them, NRXP price has a max estimate of 31.00 USD and a min estimate of 18.00 USD. Watch NRXP chart and read a more detailed NRX Pharmaceuticals, Inc. stock forecast: see what analysts think of NRX Pharmaceuticals, Inc. and suggest that you do with its stocks.
NRXP reached its all-time high on Dec 22, 2020 with the price of 769.90 USD, and its all-time low was 1.10 USD and was reached on Oct 16, 2024. View more price dynamics on NRXP chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NRXP stock is 4.17% volatile and has beta coefficient of 0.55. Track NRX Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is NRX Pharmaceuticals, Inc. there?
Today NRX Pharmaceuticals, Inc. has the market capitalization of 33.32 M, it has decreased by −4.81% over the last week.
Yes, you can track NRX Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
NRX Pharmaceuticals, Inc. is going to release the next earnings report on May 20, 2025. Keep track of upcoming events with our Earnings Calendar.
NRXP earnings for the last quarter are −0.71 USD per share, whereas the estimation was −0.37 USD resulting in a −94.22% surprise. The estimated earnings for the next quarter are −0.30 USD per share. See more details about NRX Pharmaceuticals, Inc. earnings.
NRX Pharmaceuticals, Inc. revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of 0.00 USD. In the next quarter, revenue is expected to reach 5.00 M USD.
NRXP net income for the last quarter is −9.08 M USD, while the quarter before that showed −1.62 M USD of net income which accounts for −459.33% change. Track more NRX Pharmaceuticals, Inc. financial stats to get the full picture.
No, NRXP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NRXP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NRX Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NRX Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NRX Pharmaceuticals, Inc. stock shows the sell signal. See more of NRX Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.